// App-Quantinova.ai

S2_03 : Effect of Denosumab on Osteoclast Activity of Osteolytic Lesions after Total Hip Arthroplasty: A Proof of Concept Trial

Researchers

Presenter

  • Mohit Mahatma

Principal Investigators

  • Jeremy Mark Wilkinson

  • Raveen Jayasuriya

  • Fatma Gossiel

  • Orla Gallagher

  • David Hughes

  • Simon Buckley

  • Andrew Gordon

  • Andrew Hamer

  • Mohammad Tomouk

Medical Centers

  • University of Sheffield, Sheffield, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Denosumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved